pI: 7.7653 |
Length (AA): 1700 |
MW (Da): 204533 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1345 | 1424 | 2bgw (A) | 18 | 97 | 35.00 | 0.0000092 | 1 | 0.68 | -1.97 |
1346 | 1480 | 1j23 (A) | 5 | 134 | 25.00 | 0 | 0.96 | 0.61 | -2.3 |
160 | 350 | 2p6r (A) | 4 | 184 | 11.00 | 0.18 | 0.05 | 0.0224529 | 0.22 |
530 | 751 | 4o87 (A) | 18 | 264 | 29.00 | 0.38 | 0.98 | 0.209988 | 1 |
995 | 1180 | 4uos (A) | 3 | 184 | 8.00 | 0.018 | 0 | 0.181512 | -0.75 |
1349 | 1481 | 1j23 (A) | 8 | 135 | 25.00 | 0.015 | 0.9 | 0.441035 | -0.96 |
1638 | 1700 | 2aq0 (A) | 11 | 74 | 30.00 | 0.00071 | 1 | 0.516159 | -1.52 |
45 | 293 | 5czz (A) | 626 | 923 | 29.00 | 0.44 | 0.64 | 0.085359 | 1.55 |
536 | 757 | 4o87 (A) | 18 | 264 | 29.00 | 0.42 | 0.98 | 0.208597 | 1 |
1354 | 1486 | 1j23 (A) | 8 | 135 | 25.00 | 0.036 | 0.9 | 0.441342 | -0.96 |
1641 | 1713 | 2aq0 (A) | 1 | 74 | 29.00 | 0.00045 | 1 | 0.523515 | -1.53 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | early schizont, late schizont, late trophozoite. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, gametocyte, early trophozoite, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst, Ring, Sporozoite. | Otto TD Zanghi G |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_127977)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G41150 | DNA repair endonuclease UVH1 |
Babesia bovis | BBOV_IV002550 | DNA repair endonuclease, putative |
Brugia malayi | Bm1_46945 | ERCC4 domain containing protein |
Candida albicans | CaO19.12779 | UV endonuclease |
Candida albicans | CaO19.5319 | UV endonuclease |
Candida albicans | CaO19.5318 | UV endonuclease |
Candida albicans | CaO19.12778 | UV endonuclease |
Caenorhabditis elegans | CELE_C47D12.8 | Protein C47D12.8 |
Cryptosporidium hominis | Chro.40338 | UV endonuclease; Rad1p |
Cryptosporidium parvum | cgd4_2960 | ERCC4/XP-G-type excision repair nuclease |
Cryptosporidium parvum | cgd4_2970 | RAD1, NH2 terminal ERCC4-like helicase domain |
Dictyostelium discoideum | DDB_G0284419 | DNA excision repair protein 4 |
Drosophila melanogaster | Dmel_CG3697 | meiotic 9 |
Echinococcus granulosus | EgrG_000580700 | dna repair endonuclease xpf |
Entamoeba histolytica | EHI_148310 | DNA repair endonuclease, putative |
Echinococcus multilocularis | EmuJ_000580700 | dna repair endonuclease xpf |
Homo sapiens | ENSG00000175595 | excision repair cross-complementation group 4 |
Loa Loa (eye worm) | LOAG_00528 | ERCC4 domain-containing protein |
Mus musculus | 50505 | excision repair cross-complementing rodent repair deficiency, complementation group 4 |
Neospora caninum | NCLIV_043890 | Protein C47D12.8, partially confirmed by transcript evidence, related |
Oryza sativa | 4331279 | Os03g0100400 |
Plasmodium berghei | PBANKA_1144700 | DNA repair endonuclease, putative |
Plasmodium falciparum | PF3D7_1368800 | DNA repair endonuclease, putative |
Plasmodium knowlesi | PKNH_1102400 | DNA repair endonuclease, putative |
Plasmodium vivax | PVX_115400 | DNA repair endonuclease, putative |
Plasmodium yoelii | PY04288 | DNA repair endonuclease, subunit |
Saccharomyces cerevisiae | YPL022W | Rad1p |
Schistosoma japonicum | Sjp_0081630 | ko:K01175 excision repair cross-complementing rodent repair deficiency, complementation group 4 [EC:3.1.-.-], putative |
Schistosoma japonicum | Sjp_0099170 | ko:K01175 excision repair cross-complementing rodent repair deficiency, complementation group 4 [EC:3.1.-.-], putative |
Schistosoma mansoni | Smp_153770 | DNA repair endonuclease xp-f / mei-9 / rad1 |
Schmidtea mediterranea | mk4.000684.11 | DNA repair endonuclease XPF |
Schmidtea mediterranea | mk4.000684.10 | |
Schmidtea mediterranea | mk4.000684.07 | DNA repair endonuclease XPF |
Toxoplasma gondii | TGME49_305310 | ERCC4 domain-containing protein |
Theileria parva | TP03_0395 | DNA repair endonuclease, putative |
Trichomonas vaginalis | TVAG_447530 | nuclease Rad1 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C47D12.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C47D12.8 | Caenorhabditis elegans | slow growth | wormbase |
PBANKA_1144700 | Plasmodium berghei | Slow | plasmo |
TGME49_305310 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | excision repair cross-complementation group 4 | Compounds | References |
1 literature reference was collected for this gene.